Smart chemo selection may keep bile duct cancer away longer
NCT ID NCT07296666
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests whether using a special test (3D-PTA) on a patient's tumor can help doctors pick the most effective chemotherapy after surgery for stage II/III bile duct cancer. About 98 adults who had their cancer fully or nearly fully removed will be randomly assigned to either standard chemo or a chemo chosen by the test. The goal is to see if the personalized approach delays cancer return better than the standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.